| ARISE | African Research and Innovative Initiative for Sickle Cell Education |
| BABYHUG | Hydroxyurea in Very Young Children with Sickle Cell Anemia |
| CAREST | Caribbean Network of Researchers on Sickle Cell Disease and Thalassemia |
| CE | Capillary electrophoresis |
| CONSA | Consortium on Newborn Screening in Africa |
| EXTEND | Expanding Treatment for Existing Neurological Disease |
| FDA | Food and Drug Administration |
| GAVI | Global Alliance for Vaccines and Immunization |
| HPLC | High-performance liquid chromatography |
| IEF | Isoelectric focusing |
| MS/MS | Tandem mass spectrometry |
| NBS | Newborn screening |
| NNSP | National Neonatal Screening Program |
| NOHARM | Novel use of Hydroxyurea in African Regions with Malaria |
| POC | Point-of-care |
| PROPS | Penicillin Prophylaxis in Children with Sickle Cell Anemia |
| RUSP | Recommended Uniform Screening Panel |
| SACRED | Stroke Avoidance for Children in Republica Dominicana |
| SCD | Sickle cell disease |
| SPHERE | Stroke Prevention with Hydroxyurea Enabled Through Research and Education |
| TCD | Transcranial Doppler |
| TWiTCH | Transcranial Doppler with Transfusion Changing to Hydroxyurea |
| UAE | United Arab Emirates |
| US | United States |
| WHO | World Health Organization |